ApprovalTrail

Approval · Notice of Compliance 13121 · 2012

ZYCLARA: Notice of Compliance 13121

Issued March 16, 2012

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
13121
Date
March 16, 2012
Company
Medicis Pharmaceutical CorpScottsdale, Arizona, United States
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Immune Response Modifier

Products in this notice

BrandDINStatus today
ZYCLARA02340445Marketed

Medicinal ingredients